One really cannot argue with the success of the British cycling program. As noted in an editorial in the Financial Times, in the most recent three Olympics the team has won 38 medals, 22 of which were gold.
When you add the fact that four of the past five Tour de France winners where Britons Chris Froome and Sir Bradley Wiggins, it speaks of stunning achievements.
However, “in late 2016, a series of disclosures began to change the picture.”
First were the disclosures that Sir Bradley had been given three “therapeutic use exemptions” which allowed him to receive steroid injections, allegedly for asthma. Just coincidently the steroid injections came before “big races, including his 2012 Tour victory.”
In the medical arena, there was a “mystery package” of drugs delivered to a British coach during the 2011 Tour and was never explained.
Finally, there were claims of bullying and sexism leveled against the former team director.
The world of sports often provides lessons for the compliance professional. I was interested in the lessons drawn by the UK’s leading business daily newspaper.